Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $59.4100 (-2.7%) ($59.4100 - $59.4100) on Thu. Sep. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 28 | Latest Price | $59.4100(-2.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XLC(62%) IWF(55%) IWN(45%) SKYY(37%) IWC(36%) | Factors Impacting LGND price | LGND will decline at least -0.755% in a week (0% probabilities). TAN(-79%) VXX(-76%) SLV(-26%) SIL(-26%) SPLV(-16%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $56.78(-4.43%) | Resistance Level | $63.58 | 5 Day Moving Average | $61.63(-3.6%) | 10 Day Moving Average | $62.22(-4.52%) | 20 Day Moving Average | $63.58(-6.56%) | To recent high | -22.8% | To recent low | 0% | Market Cap | $955m | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |